TomoTherapy, Vision RT team for 3D imaging technologies

TomoTherapy has partnered with Vision RT to expand imaging options for Hi-Art treatment system users. The companies are jointly introducing AlignRT 3D imaging technology for the Hi-Art platform at the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston, Sept. 21-25.

TomoTherapy will distribute AlignRT for use with both its TomoHelical and new TomoDirect delivery modes, according to the Madison, Wis.-based TomoTherapy and the London-based Vision RT.

The companies said that AlignRT for the Hi-Art platform will consist of two ceiling-mounted 3D camera units, each focused toward the external isocenter of the radiotherapy device. Prior to treatment, the patient will lie on the treatment couch for initial set-up. The cameras will then acquire a surface scan of the body in treatment position, and software will be used to register real-time image data to the reference surface scan, and—within seconds—provide new couch coordinates for patient positioning.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.